The wound therapy apparatus may include a wound interface sealingly securable to the skin surface around a wound bed to encloses the wound bed within an enclosed space that is fluid-tight. The wound interface may be sufficiently deformation resistant to distend at least a portion of the wound bed into the enclosed space when pressure p.sub.0 within the enclosed space is less than ambient pressure p.sub.amb. Fluid may be communicated with the enclosed space when the wound interface is sealingly secured to the skin surface in order to vary a pressure p.sub.0 within the enclosed space periodically over the pressure range p.sub.min≤p.sub.0≤p.sub.max. The variation of the pressure p.sub.0 may distend the wound bed into communication with a pad received within the enclosed space and decreases the wound bed contact with the pad. Related methods of use of the wound therapy apparatus are also disclosed.

Provided are drainage systems that may include a drainage manifold and may be suitable for draining fluid from a tissue site. The drainage manifold may include a plurality of elongate members having a moveable end that may be adapted to configure the drainage manifold to treat a uniquely shaped tissue site. The drainage manifold may be coupled to a drainage tube with a transitional connector to provide a drainage system capable of distributing reduced pressure to the tissue site to enhance the drainage of fluids.

Apparatus for the application of topical negative pressure therapy to a wound site is described, the apparatus comprising: a wound contacting element for retaining wound exudate fluid therein; a wound covering element that provides a substantially airtight seal over the wound contacting element and wound site; a vacuum connection tube connecting a wound cavity to a vacuum source; and a vacuum source connected to a distal end of the vacuum connection tube.

In some cases, a wound dressing comprises a substantially flexible substrate with a first, wound-facing side supporting a plurality of electronic components and a second side opposite the first side, wherein the substrate comprises a plurality of perforations formed though the substrate and wherein the plurality of perforations comprise walls on the exterior surface of the plurality of perforations, a first substantially stretchable coating applied to the first side of the substrate, and a second substantially stretchable coating applied to second side of the substrate, wherein the walls of the plurality of perforations are at least partially coated with at least one of the coatings.

A wound monitoring and/or therapy system can include a substantially stretchable substrate supporting a plurality of electronic components, including sensors, and a plurality of electronic connections that connect at least some of the electronic components. The electronic components can also include a circuit board supporting at least one controller configured to control at least some of the sensors, the circuit board configured to operate without failure when the substrate is flexed as a result of strain. A calibration track can be positioned on the substrate and connected to a monitoring circuit configured to measure a change in resistance of the calibration track indicative of resistance change of at least some of the plurality of electronic connections. The system can include a controller with a circuit board supporting a plurality of electrical components and an antenna configured to communicate with the substrate, the antenna at least partially enclosing the circuit board.

Disclosed embodiments relate to apparatuses and methods for wound treatment. In certain embodiments, a negative pressure wound therapy apparatus can include a wound dressing comprising an absorbent layer comprising a plurality of portions of absorbent material that can be physically separate from each other. In some embodiments, a wound treatment apparatus can include an absorbent layer comprising a compressed portion configured to impede the flow of fluid therethrough. In some embodiments, a wound treatment apparatus can include an absorbent layer and spacer layer positioned side by side.

A system for negative pressure and hypoxic tissue therapy including a chemical pump assembly, a dressing to cover a tissue site, a plurality of hoses, and a cover layer to cover a portion of the dressing. Each hose is configured to fluidly connect the dressing to the assembly. Oxygen flows from the dressing to a reactor in the assembly where the oxygen is consumed by the reactor. The hoses have different cross-sectional areas and selectable lengths, and these can be selected to provide a desired amount of oxygen around the tissue site. The cover layer has less permeability to air that does the dressing, nd can be used to cover a portion of the dressing to inhibit the permeation of air through the dressing and thus provide the desired amount of oxygen around the tissue site.

Described is a negative wound therapy (NPWT) dressing that includes a backing layer and an adhesive skin contact layer, the adhesive skin contact layer being configured to detachably adhere the dressing to a dermal surface, wherein the backing layer includes a coupling member. The coupling member includes a tubing configured to connect the dressing to a negative pressure source and to a remote fluid collector.

Described is a negative wound therapy (NPWT) dressing that includes a backing layer and an adhesive skin contact layer, the adhesive skin contact layer being configured to detachably adhere the dressing to a dermal surface, wherein the backing layer includes a coupling member. The coupling member includes a tubing configured to connect the dressing to a negative pressure source and to a remote fluid collector.

An apparatus for treating a tissue site includes a dressing, an oxygen source, a valve, and a negative-pressure source. The dressing is configured to be sealed around the tissue site. The oxygen source is fluidly coupled to the dressing and configured to provide a low flow of oxygen. A first port of the valve is fluidly coupled to the dressing and the valve moves between a closed position preventing flow through the valve and an open position permitting flow through the valve. The negative-pressure source is fluidly coupled to a second port of the valve and provides negative pressure to the second port of the valve at a non-therapeutic level. The valve separates the negative-pressure source from the dressing and selectively opens when a positive pressure is applied on an upstream side of the valve.